BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23455523)

  • 1. Hypermetabolic mesenteric brown adipose tissue on dual-time point FDG PET/CT in a patient with benign retroperitoneal pheochromocytoma.
    Dong A; Wang Y; Lu J; Zuo C
    Clin Nucl Med; 2014 Mar; 39(3):e229-32. PubMed ID: 23455523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intense FDG activity in the brown adipose tissue in omental and mesenteric regions in a patient with malignant pheochromocytoma.
    Cheng W; Zhu Z; Jin X; Chen L; Zhuang H; Li F
    Clin Nucl Med; 2012 May; 37(5):514-5. PubMed ID: 22475909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected visitor on FDG PET/CT--brown adipose tissue (BAT) in mesentery in a case of retroperitoneal extra-adrenal pheochromocytoma: is the BAT activation secondary to catecholamine-secreting pheochromocytoma?
    Joshi PV; Lele VR
    Clin Nucl Med; 2012 May; 37(5):e119-20. PubMed ID: 22475922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual FDG uptakes of mesenteric brown adipose tissue in a patient with pheochromocytomas.
    Li B; Zhang M; Jin J
    Nuklearmedizin; 2016 Aug; 55(4):N32-3. PubMed ID: 27492844
    [No Abstract]   [Full Text] [Related]  

  • 5. Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma.
    Kuji I; Imabayashi E; Minagawa A; Matsuda H; Miyauchi T
    Ann Nucl Med; 2008 Apr; 22(3):231-5. PubMed ID: 18498040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.
    Puar T; van Berkel A; Gotthardt M; Havekes B; Hermus AR; Lenders JW; van Marken Lichtenbelt WD; Xu Y; Brans B; Timmers HJ
    J Clin Endocrinol Metab; 2016 Jan; 101(1):224-32. PubMed ID: 26574955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
    Hadi M; Chen CC; Whatley M; Pacak K; Carrasquillo JA
    J Nucl Med; 2007 Jul; 48(7):1077-83. PubMed ID: 17574980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
    Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
    Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of catecholamines on the glucose uptake in brown adipose tissue demonstrated by (18)F-FDG PET/CT in a patient with adrenal pheochromocytoma.
    Yamaga LY; Thom AF; Wagner J; Baroni RH; Hidal JT; Funari MG
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):446-7. PubMed ID: 17909796
    [No Abstract]   [Full Text] [Related]  

  • 10. Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma.
    Fukuchi K; Tatsumi M; Ishida Y; Oku N; Hatazawa J; Wahl RL
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):601-3. PubMed ID: 15578336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of Classical β-Blocker Carvedilol to Deactivate Brown Adipose Tissue in a Patient With Pheochromocytoma.
    Tsechelidis I; El Darazi E; Muteganya R; Weyts K; Goldman S
    Clin Nucl Med; 2018 Aug; 43(8):604-605. PubMed ID: 29916915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive hypermetabolic pattern of brown adipose tissue activation on 18F-FDG PET/CT in a patient diagnosed of catecholamine-secreting para-vesical paraganglioma.
    Banzo J; Ubieto MA; Berisa MF; Andrés A; Mateo ML; Tardín L; Parra A; Razola P; Prats E
    Rev Esp Med Nucl Imagen Mol; 2013; 32(6):397-9. PubMed ID: 23867638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of brown adipose tissue by
    Santhanam P; Treglia G; Ahima RS
    J Clin Hypertens (Greenwich); 2018 Mar; 20(3):615. PubMed ID: 29443440
    [No Abstract]   [Full Text] [Related]  

  • 14. [A Case Report : FDG Uptake to Brown Adipose Tissue Activated by Elevated Serum Catecholamine in a Patient with Pheochromocytoma].
    Koh Y; Asakura T; Katayama K; Tei N; Harada Y; Nishimura K
    Hinyokika Kiyo; 2018 Nov; 64(11):435-438. PubMed ID: 30543742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation.
    Abdul Sater Z; Jha A; Hamimi A; Mandl A; Hartley IR; Gubbi S; Patel M; Gonzales M; Taïeb D; Civelek AC; Gharib AM; Auh S; O'Mara AE; Pacak K; Cypess AM
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1176-85. PubMed ID: 31903484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG Uptake in Brown Adipose Tissue Activated by a β3-Adrenergic Receptor Agonist Prescribed for Overactive Bladder.
    Okuyama C; Kikuchi R; Ikeuchi T
    Clin Nucl Med; 2020 Aug; 45(8):628-631. PubMed ID: 32453085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and pattern of brown adipose tissue distribution of 18F-FDG in patients undergoing PET-CT in a subtropical climatic zone.
    Perkins AC; Mshelia DS; Symonds ME; Sathekge M
    Nucl Med Commun; 2013 Feb; 34(2):168-74. PubMed ID: 23196673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of brown adipose tissue ¹⁸F-FDG uptake in PET/CT imaging and its influencing factors in the Chinese population.
    Shao X; Shao X; Wang X; Wang Y
    Nucl Med Biol; 2016 Jan; 43(1):7-11. PubMed ID: 26702781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of physiologic 18F-FDG uptake in brown adipose tissue in sequential PET/CT examinations.
    Pace L; Nicolai E; D'Amico D; Ibello F; Della Morte AM; Salvatore B; Pizzuti LM; Salvatore M; Soricelli A
    Mol Imaging Biol; 2011 Oct; 13(5):1029-35. PubMed ID: 20852948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
    Admiraal WM; Holleman F; Bahler L; Soeters MR; Hoekstra JB; Verberne HJ
    J Nucl Med; 2013 Feb; 54(2):208-12. PubMed ID: 23318291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.